Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Revenue Recognition

v3.20.2
Note 3 - Revenue Recognition
 6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]
3.
Revenue Recognition
 
The following table presents the Company's disaggregated revenue by offering type (in thousands):
 
   
Three Months Ended
June 30,
    
Six Months Ended
June 30,
  
   
2020
    
2019
    
2020
    
2019
  
                                 
Third-Party Payer Rentals
   $
12,752
     $
9,738
     $
23,988
     $
18,485
  
Direct Payer Rentals
    
7,940
      
6,506
      
14,800
      
12,827
  
Product Sales
    
5,307
      
3,479
      
8,764
      
6,604
  
                                 
Total - Net revenues
   $
25,999
     $
19,723
     $
47,552
     $
37,916
  
 
Third-Party Payer Rentals are entirely attributed to revenues of the Integrated Therapy Services (“ITS”) segment. Product Sales are entirely attributed to revenues of the Durable Medical Equipment Services (“DME Services”) segment. For the
three
months ended
June 30, 2020,
$2.8
million and
$5.1
million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the
three
months ended
June 30, 2019,
$2.6
million and
$3.9
million were attributed to the ITS and DME Services segments, respectively.
 
For the
six
months ended
June 30, 2020,
$5.7
million and
$9.1
million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the
six
months ended
June 30, 2019,
$5.2
million and
$7.6
million were attributed to the ITS and DME Services segments, respectively.
 
The following table presents the Company's disaggregated revenue by offering type as a percentage of total net revenues:
 
   
Three Months Ended
    
Six Months Ended
  
   
June 30,
    
June 30,
  
   
2020
    
2019
    
2020
    
2019
  
                                 
Third-Party Payer Rentals
    
49.0%
      
49.4%
      
50.5%
      
48.8%
  
Direct Payer Rentals
    
30.6%
      
33.0%
      
31.1%
      
33.8%
  
Product Sales
    
20.4%
      
17.6%
      
18.4%
      
17.4%
  
                                 
Total - Net revenues
    
100.0%
      
100.0%
      
100.0%
      
100.0%